Optimisation of circulating biomarkers of obatoclax-induced cell death in patients with SCLC, to inform future trial design

EJ Dean, J Cummings, Anne Roulston, Mark Berger, M Ranson, F Blackhall, C Dive

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)339-347
JournalNeoplasia
Volume13
Issue number4
Publication statusPublished - Apr 2011

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Cite this